Evidence-based Treatment Options in Cannabis Dependency

被引:15
|
作者
Walther, Lisa [1 ]
Gantner, Andreas [2 ]
Heinz, Andreas [1 ,3 ]
Majic, Tomislav [3 ]
机构
[1] Charite, Dept Psychiat & Psychotherapy, Campus Mitte, Berlin, Germany
[2] Therapieladen eV, Berlin, Germany
[3] Charite, St Hedwig Hosp, Dept Psychiat & Psychotherapy, Charite Campus Mitte, Berlin, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2016年 / 113卷 / 39期
关键词
RANDOMIZED CONTROLLED-TRIAL; MULTIDIMENSIONAL FAMILY-THERAPY; COGNITIVE-BEHAVIORAL THERAPY; PLACEBO-CONTROLLED TRIAL; STUDENT MARIJUANA USE; DOUBLE-BLIND; USE DISORDERS; TREATMENT PROGRAM; MOTIVATIONAL ENHANCEMENT; BRIEF INTERVENTION;
D O I
10.3238/arztebl.2016.0653
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Now that the consumption of natural and synthetic cannabinoids is becoming more widespread, the specific treatment of cannabis-related disturbances is an increasingly important matter. There are many therapeutic options, and it is not always clear which ones are evidence-based and appropriate for use in a given clinical situation. Methods: This review is based on reports of pertinent randomized and controlled trials (RCTs) that were retrieved by a selective search in the PubMed and Cochrane databases. Results: Cognitive behavior therapy (CBT) combined with other techniques has been found to have a moderate to large effect (Cohen's d = 0.53-0.9) on the amount of cannabis consumed as well as on the level of psychosocial functioning or the dependence syndrome. Systemic multidimensional family therapy (MDFT) has been found beneficial for younger adolescents who consume large amounts of cannabis and have psychiatric comorbidities. Short-term interventions with motivational talk therapy have been found effective for patients with or without an initial desire to achieve cannabis abstinence. All of these psychotherapeutic interventions are effective at evidence level Ia. The administration of gabapentin had a weak effect (d = 0.26) on the quantity consumed and on abstinence (evidence level Ib). Withdrawal symptoms can be alleviated with cannabinoid-receptor antagonists (d = 0.223 and 0.481) (evidence level Ib). On the other hand, there is evidence that serotonergic antidepressants can worsen withdrawal manifestations and increase the likelihood of relapse. Conclusion: Psychotherapeutic techniques remain the foundation of treatment for cannabis dependence. No drug has yet been approved for the treatment of cannabis dependence because of the lack of scientific evidence. The rates of abstinence that are currently achieved, even with psychotherapy, are still only moderate. Further clinical studies are needed for the evaluation of combinations of various treatments that can meet the needs of individual patients.
引用
收藏
页码:653 / +
页数:9
相关论文
共 50 条
  • [21] An Evidence-Based Review of Insomnia Treatment in Early Recovery
    Kaplan, Katherine A.
    McQuaid, John
    Primich, Charles
    Rosenlicht, Nicholas
    JOURNAL OF ADDICTION MEDICINE, 2014, 8 (06) : 389 - 394
  • [22] Evidence-based pharmacological treatment of generalized anxiety disorder
    Baldwin, David S.
    Waldman, Sarah
    Allgulander, Christer
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2011, 14 (05) : 697 - 710
  • [23] Evidence-Based Treatment Approach to Autism Spectrum Disorders
    Munshi, Kaizad R.
    Gonzalez-Heydrich, Joseph
    Augenstein, Tara
    D'Angelo, Eugene J.
    PEDIATRIC ANNALS, 2011, 40 (11): : 569 - 574
  • [24] Evidence-based treatment of atopic dermatitis with topical moisturizers
    Micali, Giuseppe
    Paterno, Valentina
    Cannarella, Rossella
    Dinotta, Franco
    Lacarrubba, Francesco
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2018, 153 (03): : 396 - 402
  • [25] Evidence-based treatment of chronic rhinosinusitis with nasal polyps
    Schlosser, Rodney J.
    Soler, Zachary M.
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2013, 27 (06) : 461 - 466
  • [26] Treatment of schizoaffective disorder - a challenge for evidence-based psychiatry
    Jaeger, M.
    Becker, T.
    Weinmann, S.
    Frasch, K.
    ACTA PSYCHIATRICA SCANDINAVICA, 2010, 121 (01) : 22 - 32
  • [27] Current and future evidence-based acne treatment: a review
    Sandoval, Laura F.
    Hartel, Jennifer K.
    Feldman, Steven R.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (02) : 173 - 192
  • [28] Evidence-Based Pharmacologic Treatment of Pediatric Bipolar Disorder
    Findling, Robert L.
    JOURNAL OF CLINICAL PSYCHIATRY, 2016, 77
  • [29] What to Do When Evidence-Based Treatment Manuals Are Not Enough? Adapting Evidence-Based Psychological Interventions for Primary Care
    Sawchuk, Craig N.
    Mulholland, Hannah
    Trane, Sarah
    Lebow, Jocelyn R.
    Puspitasari, Ajeng
    Lombardi, Nathaniel
    COGNITIVE AND BEHAVIORAL PRACTICE, 2020, 27 (04) : 377 - 391
  • [30] A Narrative Review of Evidence-Based Preventive Options for Chronic Migraine
    Starling, Amaal J.
    Vargas, Bert B.
    CURRENT PAIN AND HEADACHE REPORTS, 2015, 19 (10)